Barriers, nephrotoxicology and chronic testing in vitro.
In many organs of the human body, there are effective physiological barriers which contribute to regulation of the uptake, transport and secretion of endogenous and exogenous materials. ECVAM is involved in the development of several in vitro models for detecting damage to various barriers, for example, the renal epithelium, the intestinal barrier, and the blood-brain barrier, after acute and chronic exposure to chemicals and products of various kinds. Long-term toxicity testing is an important issue in toxicology. At present, there are no generally accepted in vitro models available for replacing chronic testing in animals. Under chronic exposure conditions, the cellular response is larger than that which can be predicted in the standard cytotoxicity models. Therefore, the approach to predicting chronic toxicity will need to involve more-complex in vitro models. Several in vitro long-term toxicity systems currently available are under evaluation.
Prieto
Pilar
P
ECVAM, Institute for Health & Consumer Protection, European Commission Joint Research Centre, 21020 Ispra (VA), Italy.
D000826:Animal Testing Alternatives; D002199:Capillary Permeability / Q000502:physiology*; D002460:Cell Line; D004847:Epithelial Cells / Q000187:drug effects / Q000473:pathology; D005062:European Union; D066298:In Vitro Techniques; D007674:Kidney Diseases / Q000139:chemically induced* / Q000473:pathology; D015203:Reproducibility of Results; D036401:Toxicity Tests, Chronic / Q000379:methods*; D015262:Xenobiotics / Q000493:pharmacokinetics* / Q000633:toxicity*
D015262:Xenobiotics